Erratum
for
Shimabukuro-Vornhagen et al., J Clin Oncol 23 (24) 5739-5745.
Journal of Clinical Oncology, Vol 24, No 14 (May 10), 2006: pp. 2220
© 2006 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2006.03.004
ERRATUM
The August 20, 2005, article by Shimabukuro-Vornhagen et al, entitled "Lymphocyte-Rich Classical Hodgkin’s Lymphoma: Clinical Presentation and Treatment Outcome in 100 Patients Treated Within German Hodgkin’s Study Group Trials" (J Clin Oncol 23:5739-5745, 2005), contained errors.
In the Results section of the Abstract, the second to last sentence was given as, "The event-free and overall survival rates were 97% (95% CI, 96.7% to 96.9%) and 97% (95% CI, 96.8% to 97.0%), respectively, at 30 months," whereas it should have read, "The event-free and overall survival rates were 97% (95% CI, 93% to 100%) and 97% (95% CI, 93% to 100%), respectively, at 30 months." However, this does not affect the validity and interpretation of the data.
In the Discussion, the second sentence in the fourth paragraph was given as, "in the European Task Force on Lymphoma study, only patients with LRCHL who were previously misclassified as having LRCHL were reviewed," whereas it should have read, "In the European Task Force on Lymphoma study, only patients with LRCHL who were previously misclassified as having LPHL were reviewed."
In Table 2, under Risk Factors, the second to last characteristics was given as > 3 LNAs, whereas it should have been  3 LNAs.
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Facebook  Reddit  Technorati  Twitter What's this?
|
